Crossmark

Cost-effectiveness analysis of interferon beta-1b as treatment for patients with clinically isolated syndrome suggestive of multiple sclerosis in Spain

Crossref DOI link: https://doi.org/10.1016/j.nrleng.2015.03.005

Published Print: 2016-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Piñol, C.
License Information

Text and Data Mining valid from 2016-05-01

Version of Record valid from 2016-12-31
More Information

This article is maintained by: Elsevier

Article Title: Cost-effectiveness analysis of interferon beta-1b as treatment for patients with clinically isolated syndrome suggestive of multiple sclerosis in Spain

Journal Title: Neurología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nrleng.2015.03.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nrl.2015.03.014

Content Type: article

Copyright: © 2014 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below